{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:37:25Z","timestamp":1790620645114,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012249","name":"Jiangxi University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["CXTD22001"],"award-info":[{"award-number":["CXTD22001"]}],"id":[{"id":"10.13039\/501100012249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016910","name":"Shenzhen Medical Information Institute","doi-asserted-by":"publisher","award":["B2302051"],"award-info":[{"award-number":["B2302051"]}],"id":[{"id":"10.13039\/100016910","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phymed.2026.158205","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:52:14Z","timestamp":1777567934000},"page":"158205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rosmarinic acid inhibits non-small cell lung cancer progression by directly targeting KRASG12C and modulating the KRAS\/AKT\/ERK signaling axis"],"prefix":"10.1016","volume":"159","author":[{"given":"Wentong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehai","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Kwan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0575-0105","authenticated-orcid":false,"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phymed.2026.158205_bib0001","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/2159-8290.CD-20-1616","article-title":"Mechanisms of resistance to KRASG12C-targeted therapy","volume":"11","author":"Akhave","year":"2021","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.phymed.2026.158205_bib0002","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/nu12061739","article-title":"Anticancer activity of Rosmarinus officinalis L.: mechanisms of action and therapeutic potentials","volume":"12","author":"Allegra","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40164-023-00453-8","article-title":"The current landscape of using direct inhibitors to target KRASG12C-mutated NSCLC","volume":"12","author":"Batrash","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.phymed.2026.158205_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.609756","article-title":"Short chain (\u2264 C4) esterification increases bioavailability of rosmarinic acid and its potency to inhibit vascular smooth muscle cell proliferation","author":"Bla\u017eevi\u0107","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158205_bib0005","first-page":"23","article-title":"Emerging strategies to target RAS signaling in human cancer therapy","author":"Chen","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.phymed.2026.158205_bib0006","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1053\/j.gastro.2013.01.071","article-title":"Roles for KRAS in pancreatic tumor development and progression","volume":"144","author":"Di Magliano","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2026.158205_bib0007","first-page":"12170","article-title":"Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients","author":"Falk","year":"2018","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.phymed.2026.158205_bib0008","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/biof.1929","article-title":"Effects of rosmarinic acid, carnosic acid, rosmanol, carnosol, and ursolic acid on the pathogenesis of respiratory diseases","volume":"49","author":"Farhadi","year":"2023","journal-title":"Biofactors"},{"key":"10.1016\/j.phymed.2026.158205_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101377","article-title":"A functionalized hydroxydopamine quinone links thiol modification to neuronal cell death","author":"Farzam","year":"2020","journal-title":"Redox. Biol."},{"issue":"12","key":"10.1016\/j.phymed.2026.158205_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108296","article-title":"Chemical proteomic profiling with photoaffinity labeling strategy identifies antimalarial targets of artemisinin","volume":"34","author":"Gao","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"2","key":"10.1016\/j.phymed.2026.158205_bib0011","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1002\/imt2.176","article-title":"Photoaffinity probe-based antimalarial target identification of artemisinin in the intraerythrocytic developmental cycle of Plasmodium falciparum","volume":"3","author":"Gao","year":"2024","journal-title":"Imeta."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12929-025-01121-1","article-title":"miR-193b-3p suppresses lung cancer cell migration and invasion through PRNP targeting","volume":"32","author":"Ho","year":"2025","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0014","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1080\/21655979.2021.1941699","article-title":"Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17\/EGFR\/AKT\/GSK3\u03b2 axis","volume":"12","author":"Huang","year":"2021","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.phymed.2026.158205_bib0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cell.2018.01.006","article-title":"Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor","volume":"172","author":"Janes","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phymed.2026.158205_bib0016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2204619","article-title":"Adagrasib in non\u2013small-cell lung cancer harboring a KRASG12C mutation","volume":"387","author":"J\u00e4nne","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phymed.2026.158205_bib0017","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neo.2021.05.002","article-title":"Rosmarinic acid represses colitis-associated colon cancer: a pivotal involvement of the TLR4-mediated NF-\u03bab-STAT3 axis","volume":"23","author":"Jin","year":"2021","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0018","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12929-024-01060-3","article-title":"Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage","volume":"31","author":"Kotani","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"11","key":"10.1016\/j.phymed.2026.158205_bib0019","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3390\/antiox13111313","article-title":"The role of Rosmarinic acid in cancer prevention and therapy: mechanisms of antioxidant and anticancer activity","volume":"13","author":"Kowalczyk","year":"2024","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.phymed.2026.158205_bib0020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ptr.6584","article-title":"Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway","volume":"34","author":"Liao","year":"2020","journal-title":"PhytOther Res."},{"key":"10.1016\/j.phymed.2026.158205_bib0021","first-page":"47095","article-title":"The superior efficacy of anti-PD-1\/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.phymed.2026.158205_bib0022","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00216-024-05257-1","article-title":"Simultaneous determination of diquat, paraquat, glufosinate, and glyphosate in plasma by liquid chromatography\/tandem mass spectrometry: from method development to clinical application","volume":"416","author":"Liu","year":"2024","journal-title":"Anal. Bioanal. Chem."},{"issue":"9","key":"10.1016\/j.phymed.2026.158205_bib0023","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-022-05259-w","article-title":"Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.phymed.2026.158205_bib0024","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1039\/C5CS00911A","article-title":"Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view","volume":"45","author":"Lu","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phymed.2026.158205_bib0025","article-title":"Icaritin ameliorates cisplatin-induced mitochondrial metabolic dysfunction-associated nephrotoxicity and synergistically potentiates its antitumor efficacy","author":"Luo","year":"2025","journal-title":"Adv. Sci."},{"issue":"5","key":"10.1016\/j.phymed.2026.158205_bib0026","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0027","article-title":"The current understanding on the impact of KRAS on colorectal cancer","volume":"140","author":"Meng","year":"2021","journal-title":"Biomed. PharmacOther"},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0028","article-title":"Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells","volume":"885","author":"Messeha","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.phymed.2026.158205_bib0029","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.molcel.2024.06.027","article-title":"Functional and structural insights into RAS effector proteins","volume":"84","author":"Mozzarelli","year":"2024","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.phymed.2026.158205_bib0030","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1021\/ci500760m","article-title":"Solvent accessible surface area-based hot-spot detection methods for protein\u2013protein and protein\u2013nucleic acid interfaces","volume":"55","author":"Munteanu","year":"2015","journal-title":"J. Chem. Inf. Model"},{"issue":"15","key":"10.1016\/j.phymed.2026.158205_bib0031","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.3390\/app9153139","article-title":"Therapeutic potential of rosmarinic acid: a comprehensive review","volume":"9","author":"Nadeem","year":"2019","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0032","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12885-019-5997-2","article-title":"Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer","volume":"19","author":"Nam","year":"2019","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.phymed.2026.158205_bib0033","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/17460441.2024.2387856","article-title":"Molecular dynamics simulations for the structure-based drug design: targeting small-GTPases proteins","volume":"19","author":"Parise","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.phymed.2026.158205_bib0034","doi-asserted-by":"crossref","first-page":"346","DOI":"10.21037\/tlcr-22-639","article-title":"Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development\u2014a narrative review","volume":"12","author":"Santarpia","year":"2023","journal-title":"Transl. Lung Cancer Res."},{"issue":"7","key":"10.1016\/j.phymed.2026.158205_bib0035","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.3390\/ijms23073706","article-title":"Small-molecule RAS inhibitors as anticancer agents: discovery, development, and mechanistic studies","volume":"23","author":"Shetu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.phymed.2026.158205_bib0036","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for lung cancers with KRAS p. G12C mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158205_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2025.126430","article-title":"Near-infrared lipid droplet polarity fluorescent probe based on phenothiazine derivative for diagnosis of non-alcoholic fatty liver and tumors","volume":"341","author":"Sun","year":"2025","journal-title":"Spectrochimica Acta Part A: Molecular Biomolecular Spectroscopy"},{"issue":"4","key":"10.1016\/j.phymed.2026.158205_bib0038","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2016.03.029","article-title":"Oncogenic KRAS regulates tumor cell signaling via stromal reciprocation","volume":"165","author":"Tape","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0039","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12964-021-00712-3","article-title":"Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage","volume":"19","author":"Ternet","year":"2021","journal-title":"Cell Commun. Signaling"},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41419-025-08101-1","article-title":"Oncogenic KRAS mutations drive immune suppression through immune-related regulatory network and metabolic reprogramming","volume":"16","author":"Tian","year":"2025","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.phymed.2026.158205_bib0041","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/biom14070867","article-title":"Therapeutic applications of rosmarinic acid in cancer-chemotherapy-associated resistance and toxicity","volume":"14","author":"Villegas","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.phymed.2026.158205_bib0042","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1074\/mcp.M113.029793","article-title":"A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis","volume":"13","author":"Wang","year":"2014","journal-title":"Mol. Cell Proteomics."},{"issue":"23","key":"10.1016\/j.phymed.2026.158205_bib0043","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1002\/1521-3773(20001201)39:23<4192::AID-ANIE4192>3.0.CO;2-Y","article-title":"Ras\u2014a molecular switch involved in tumor formation","volume":"39","author":"Wittinghofer","year":"2000","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0044","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-025-03369-9","article-title":"RASON promotes KRASG12C-driven tumor progression and immune evasion in non-small cell lung cancer","volume":"44","author":"Wu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cac2.12377","article-title":"Targeting RAS mutants in malignancies: successes, failures, and reasons for hope","volume":"43","author":"Yang","year":"2023","journal-title":"Cancer Commun."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0046","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-024-01631-9","article-title":"RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms","volume":"17","author":"Yang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0047","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7150\/ijbs.84591","article-title":"SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGF\u03b21\/smad signaling pathway","volume":"20","author":"Yao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2026.158205_bib0048","article-title":"Current status of KRAS G12C inhibitors in NSCLC and the potential for combination with anti-PD-(L) 1 therapy: a systematic review","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.phymed.2026.158205_bib0049","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.chembiol.2022.06.011","article-title":"Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"10","key":"10.1016\/j.phymed.2026.158205_bib0050","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/biom12101410","article-title":"Rosmarinic acid and related dietary supplements: potential applications in the prevention and treatment of cancer","volume":"12","author":"Zhao","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.phymed.2026.158205_bib0051","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-022-01629-2","article-title":"Targeting KRAS mutant cancers: from druggable therapy to drug resistance","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol. Cancer"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132600440X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132600440X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:56:11Z","timestamp":1785905771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S094471132600440X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"alternative-id":["S094471132600440X"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158205","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosmarinic acid inhibits non-small cell lung cancer progression by directly targeting KRASG12C and modulating the KRAS\/AKT\/ERK signaling axis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158205"}}